Subscribe To
Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that Ivana Magovčević-Liebisch, Ph.D., J.D., President and Chief Executive Officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on […] The post Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare...
Read More
Posted: Jan 3 2023, 12:00
Author Name: forextv
Views: 110847